• ag真人国际厅|(集团)点击登录

    新闻资讯
    您的地位:首页>新闻资讯>行业新闻
    异体间充质干细胞医治骨枢纽关头炎获得临床新停顿
    ###        泉源:

    国际干细胞着名杂志Stem Cells最新宣布了两篇文章,Tommy和他的同事们选取了35例软骨缺损病人,将异体MSC混淆10%或20%的自体软骨构造对他们举行医治,并举行18个月随访。后果发明缺损部位有软骨构造再生,构造学剖析发明有高浓度的卵白聚糖和II型胶原通明样再生,再生构造中仅含有患者本身的DNA,且后果支持异体MSC经过旁排泄效应安慰病人自体构造修复。

    寰俊鍥剧墖_20191016145613.png

     

    Reference:

    de Windt T S, Vonk L A, Slaper-Cortenbach I C, etal. Allogeneic Mesenchymal Stem Cells Stimulate Cartilage Regeneration and AreSafe for Single-Stage Cartilage Repair in Humans upon Mixture with RecycledAutologous Chondrons[J]. Stem Cells, 2017, 35(1):256.


    de Windt TS, Vonk LA, Slaper-Cortenbach ICM, etal. Allogeneic MSCs and Recycled Autologous Chondrons Mixed in a One-stageCartilage Cell Transplantion A First-in-man Trial in 35 Patients[J]. Stem cells(Dayton, Ohio), 2017.